Cancer biomarker discovery via targeted profiling of multiclass tumor tissue-derived proteomes

Clinical Proteomics

Volumn 5, Issue 3-4, 2009, Pages 163-169

  Zhou, Longhai ^a   Cai, Ming ^b   Ling, Xuefeng Bruce ^c   Wang, Qiang ^b   Lau, Kenneth ^c   Zhao, Jiagang Jack ^d   Schilling, James ^c   Chen, Liangbiao ^a  

^a INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c STANFORD UNIVERSITY   (United States)

^d Stemnex Inc   (United States)

Author keywords

Biomarker panel; Cancer classification; Proteomics

Indexed keywords

BIOLOGICAL MARKER; PEPTIDE; PROTEOME; SCLEROPROTEIN; TUMOR MARKER;

APOPTOSIS; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER TISSUE; CELL DEATH; CELL SECRETION; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; DISEASE MARKER; EXTRACELLULAR MATRIX; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CANCER; LIQUID CHROMATOGRAPHY; LIVER CANCER; MASS SPECTROMETRY; PEPTIDOMICS; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN STRUCTURE; PROTEIN TARGETING; PROTEOMICS; SEROLOGY;

EID: 72949123017     PISSN: 15426416     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12014-009-9037-0     Document Type: Article

References (22)

1. EP Diamandis 2004 Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems J Natl Cancer Inst 96 353 356 14996856
2. EP Diamandis DE van der Merwe 2005 Plasma protein profiling by mass spectrometry for cancer diagnosis: opportunities and limitations Clin Cancer Res 11 963 965 1:CAS:528:DC%2BD2MXht1ynuro%3D 15709159
3. H Zhang DW Chan 2007 Cancer biomarker discovery in plasma using a tissue-targeted proteomic approach Cancer Epidemiol Biomarkers Prev 16 1915 1917 10.1158/1055-9965.EPI-07-0420 1:CAS:528:DC%2BD2sXhtFGjtLfI 17932335 (Pubitemid 47621162)
4. WJ Qian JM Jacobs T Liu DG Camp 2nd RD Smith 2006 Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications Mol Cell Proteomics 5 1727 1744 10.1074/mcp.M600162-MCP200 1:CAS:528:DC%2BD28XhtFGqsbnE 16887931 (Pubitemid 44696109)
5. A Keller AI Nesvizhskii E Kolker R Aebersold 2002 Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search Anal Chem 74 5383 5392 10.1021/ac025747h 1:CAS:528: DC%2BD38XmvVyktL4%3D 12403597 (Pubitemid 35215372)
6. EM Fach LA Garulacan J Gao Q Xiao SM Storm YP Dubaquie et al 2004 In vitro biomarker discovery for atherosclerosis by proteomics Mol Cell Proteomics 3 1200 1210 10.1074/mcp.M400160-MCP200 1:CAS:528:DC%2BD2MXhvFarug%3D%3D 15496433
7. J Gao GJ Opiteck MS Friedrichs AR Dongre SA Hefta 2003 Changes in the protein expression of yeast as a function of carbon source J Proteome Res 2 643 649 10.1021/pr034038x 1:CAS:528:DC%2BD3sXns1Wls70%3D 14692458 (Pubitemid 38017109)
8. R Tibshirani T Hastie B Narasimhan S Soltys G Shi A Koong et al 2004 Sample classification from protein mass spectrometry, by 'peak probability contrasts' Bioinformatics 20 3034 3044 10.1093/bioinformatics/bth357 1:CAS:528:DC%2BD2cXhtVSrur%2FE 15226172 (Pubitemid 39619195)
9. Y Yasui M Pepe ML Thompson BL Adam GL Wright Jr Y Qu et al 2003 A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection Biostatistics 4 449 463 10.1093/biostatistics/4.3.449 12925511 (Pubitemid 36810096)
10. JS Lam JT Leppert RA Figlin AS Belldegrun 2005 Role of molecular markers in the diagnosis and therapy of renal cell carcinoma Urology 66 1 9 10.1016/j.urology.2005.06.112 16194700 (Pubitemid 41356552)
11. AA Khalil 2007 Biomarker discovery: a proteomic approach for brain cancer profiling Cancer Sci 98 201 213 10.1111/j.1349-7006.2007.00374.x 1:CAS:528:DC%2BD2sXhsFKjtb0%3D 17233837 (Pubitemid 44941872)
12. K Bernacka A Kuryliszyn-Moskal S Sierakowski 1988 The levels of alpha 1-antitrypsin and alpha 1-antichymotrypsin in the sera of patients with gastrointestinal cancers during diagnosis Cancer 62 1188 1193 10.1002/1097-0142(19880915)62:6<1188::AID-CNCR2820620624>3.0.CO;2-E 1:STN:280:DyaL1czhtVOlug%3D%3D 3261623 (Pubitemid 18206341)
13. Z Chen J Gu 2007 Immunoglobulin G expression in carcinomas and cancer cell lines FASEB J 21 2931 2938 10.1096/fj.07-8073com 17475920 (Pubitemid 47372759)
14. S Mazurek CB Boschek F Hugo E Eigenbrodt 2005 Pyruvate kinase type M2 and its role in tumor growth and spreading Semin Cancer Biol 15 300 308 10.1016/j.semcancer.2005.04.009 1:CAS:528:DC%2BD2MXmvVKntbw%3D 15908230 (Pubitemid 41058775)
15. I Brotherick CN Robson DA Browell J Shenfine MD White WJ Cunliffe et al 1998 Cytokeratin expression in breast cancer: phenotypic changes associated with disease progression Cytometry 32 301 308 10.1002/(SICI)1097-0320(19980801)32: 4<301::AID-CYTO7>3.0.CO;2-K 1:STN:280:DyaK1czmsFWhuw%3D%3D 9701399 (Pubitemid 28345954)
16. H Matsuura S Nakazawa 1985 Prognostic significance of serum alpha 1-acid glycoprotein in patients with glioblastoma multiforme: a preliminary communication J Neurol Neurosurg Psychiatry 48 835 837 10.1136/jnnp.48.8.835 1:STN:280:DyaL2M3ptFyqsg%3D%3D 2993530
17. ME Lenburg LS Liou NP Gerry GM Frampton HT Cohen MF Christman 2003 Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data BMC Cancer 3 31 10.1186/1471-2407-3-31 14641932 (Pubitemid 38851319)
18. J Villanueva DR Shaffer J Philip CA Chaparro H Erdjument-Bromage AB Olshen et al 2006 Differential exoprotease activities confer tumor-specific serum peptidome patterns J Clin Invest 116 271 284 10.1172/JCI26022 1:CAS:528:DC%2BD28XjslOgtQ%3D%3D 16395409 (Pubitemid 43121812)
19. R Tibshirani T Hastie B Narasimhan G Chu 2002 Diagnosis of multiple cancer types by shrunken centroids of gene expression Proc Natl Acad Sci USA 99 6567 6572 10.1073/pnas.082099299 1:CAS:528:DC%2BD38XjvFCktbg%3D 12011421 (Pubitemid 34526173)
20. J Villanueva AJ Martorella K Lawlor J Philip M Fleisher RJ Robbins et al 2006 Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age Mol Cell Proteomics 5 1840 1852 10.1074/mcp.M600229-MCP200 1:CAS:528:DC%2BD28XhtFGqsbbL 16896061 (Pubitemid 44688193)
21. J Villanueva A Nazarian K Lawlor SS Yi RJ Robbins P Tempst 2008 A sequence-specific exopeptidase activity test (SSEAT) for "functional" biomarker discovery Mol Cell Proteomics 7 509 518 1:CAS:528:DC%2BD1cXjsFygtrY%3D 17986438
22. JM Koomen D Li LC Xiao TC Liu KR Coombes J Abbruzzese et al 2005 Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery J Proteome Res 4 972 981 10.1021/pr050046x 1:CAS:528:DC%2BD2MXkt1Kltr0%3D 15952745 (Pubitemid 40863287)